Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Updates Financial Guidance: Cash Runway Further Extended Into Second Half of 2013 Feb 29, 2012 Tekmira Updates Financial Guidance: Cash Runway Further Extended Into Second Half of 2013 20.7 KB ... Read more Summary ToggleTekmira Announces USPTO Issuance of Key Patents Broadly Covering LNP Formulations and Mitigation of Immune Stimulation Feb 09, 2012 Tekmira Announces USPTO Issuance of Key Patents Broadly Covering LNP Formulations and Mitigation of Immune Stimulation 18.2 KB ... Read more Summary ToggleTekmira Announces Initiation of TKM-Ebola Phase 1 Clinical Trial Feb 08, 2012 Tekmira Announces Initiation of TKM-Ebola Phase 1 Clinical Trial 22.7 KB Ongoing Collaboration With US Government Advances LNP Technology ... Read more Summary ToggleTekmira Provides Periodic Update to Litigation Jan 17, 2012 Tekmira Provides Periodic Update to Litigation 18.2 KB ... Read more Summary ToggleTekmira Granted an Injunction Against Certain Individuals From AlCana Technologies by the Supreme Court of British Columbia Jan 10, 2012 Tekmira Granted an Injunction Against Certain Individuals From AlCana Technologies by the Supreme Court of British Columbia 18.4 KB Injunction Orders Confidential Information to be Returned to Tekmira ... Read more Summary ToggleTekmira's LNP Technology Enables Alnylam's Positive ALN-PCS Clinical Data Jan 04, 2012 Tekmira's LNP Technology Enables Alnylam's Positive ALN-PCS Clinical Data 19.5 KB ... Read more Summary ToggleTekmira Provides Periodic Update to Litigation Dec 21, 2011 Tekmira Provides Periodic Update to Litigation 18.5 KB ... Read more Summary ToggleTekmira Secures $3 Million Financing Dec 21, 2011 Tekmira Secures $3 Million Financing 18.5 KB Financial Guidance Updated: Cash Runway Further Extended Into 2013 ... Read more Summary ToggleTekmira Pharmaceuticals Receives Approval from FDA to Initiate TKM-Ebola Phase 1 Clinical Trial Nov 28, 2011 Tekmira Pharmaceuticals Receives Approval from FDA to Initiate TKM-Ebola Phase 1 Clinical Trial 21.8 KB ... Read more Summary ToggleTekmira's LNP Technology Enables Alnylam's ALN-TTR01 Clinical Data Nov 21, 2011 Tekmira's LNP Technology Enables Alnylam's ALN-TTR01 Clinical Data 19.7 KB Tekmira Comments on Phase I Clinical Data for ALN-TTR01 Presented at International Symposium ... Read more Pagination First page First Previous page Previous … Page 39 Current page 40 Page 41 Page 42 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Updates Financial Guidance: Cash Runway Further Extended Into Second Half of 2013 Feb 29, 2012 Tekmira Updates Financial Guidance: Cash Runway Further Extended Into Second Half of 2013 20.7 KB ... Read more Summary ToggleTekmira Announces USPTO Issuance of Key Patents Broadly Covering LNP Formulations and Mitigation of Immune Stimulation Feb 09, 2012 Tekmira Announces USPTO Issuance of Key Patents Broadly Covering LNP Formulations and Mitigation of Immune Stimulation 18.2 KB ... Read more Summary ToggleTekmira Announces Initiation of TKM-Ebola Phase 1 Clinical Trial Feb 08, 2012 Tekmira Announces Initiation of TKM-Ebola Phase 1 Clinical Trial 22.7 KB Ongoing Collaboration With US Government Advances LNP Technology ... Read more Summary ToggleTekmira Provides Periodic Update to Litigation Jan 17, 2012 Tekmira Provides Periodic Update to Litigation 18.2 KB ... Read more Summary ToggleTekmira Granted an Injunction Against Certain Individuals From AlCana Technologies by the Supreme Court of British Columbia Jan 10, 2012 Tekmira Granted an Injunction Against Certain Individuals From AlCana Technologies by the Supreme Court of British Columbia 18.4 KB Injunction Orders Confidential Information to be Returned to Tekmira ... Read more Summary ToggleTekmira's LNP Technology Enables Alnylam's Positive ALN-PCS Clinical Data Jan 04, 2012 Tekmira's LNP Technology Enables Alnylam's Positive ALN-PCS Clinical Data 19.5 KB ... Read more Summary ToggleTekmira Provides Periodic Update to Litigation Dec 21, 2011 Tekmira Provides Periodic Update to Litigation 18.5 KB ... Read more Summary ToggleTekmira Secures $3 Million Financing Dec 21, 2011 Tekmira Secures $3 Million Financing 18.5 KB Financial Guidance Updated: Cash Runway Further Extended Into 2013 ... Read more Summary ToggleTekmira Pharmaceuticals Receives Approval from FDA to Initiate TKM-Ebola Phase 1 Clinical Trial Nov 28, 2011 Tekmira Pharmaceuticals Receives Approval from FDA to Initiate TKM-Ebola Phase 1 Clinical Trial 21.8 KB ... Read more Summary ToggleTekmira's LNP Technology Enables Alnylam's ALN-TTR01 Clinical Data Nov 21, 2011 Tekmira's LNP Technology Enables Alnylam's ALN-TTR01 Clinical Data 19.7 KB Tekmira Comments on Phase I Clinical Data for ALN-TTR01 Presented at International Symposium ... Read more Pagination First page First Previous page Previous … Page 39 Current page 40 Page 41 Page 42 … Next page Next Last page Last
Tekmira Announces USPTO Issuance of Key Patents Broadly Covering LNP Formulations and Mitigation of Immune Stimulation 18.2 KB
Tekmira Granted an Injunction Against Certain Individuals From AlCana Technologies by the Supreme Court of British Columbia 18.4 KB
Tekmira Pharmaceuticals Receives Approval from FDA to Initiate TKM-Ebola Phase 1 Clinical Trial 21.8 KB
